ClinicalTrials.Veeva

Menu

Study Comparing One Versus Two Cortisone Injections for Trigger Finger

Rothman Institute Orthopaedics logo

Rothman Institute Orthopaedics

Status

Unknown

Conditions

Trigger Finger
Stenosing Tenosynovitis

Treatments

Drug: One cortisone injection
Drug: Two cortisone Injections

Study type

Interventional

Funder types

Other

Identifiers

NCT00951236
RIUCLEI 09-01

Details and patient eligibility

About

Trigger finger, also known as stenosing tenosynovitis, is a painful condition that can cause discomfort and disability. Many physicians choose to locally inject cortisone into the infected finger although there is no current consensus as to how many injections are needed to achieve maximum relief. This study will be a prospective, randomized study to compare one versus two injections for the treatment of trigger finger.

Enrollment

392 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subject is greater than 18 years of age, presenting with stenosing tenosynovitis.
  • Subject is willing and able to provide informed consent.

Exclusion criteria

  • Patients who have previously undergone surgery for the treatment of trigger finger.

Trial design

392 participants in 2 patient groups

One injection
Active Comparator group
Treatment:
Drug: One cortisone injection
Two Injections
Active Comparator group
Treatment:
Drug: Two cortisone Injections

Trial contacts and locations

7

Loading...

Central trial contact

Charles Leinberry, MD; Tiffany Morrison, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems